33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of sotorasib in KRAS p.G12C-mutated NSCLC with stable brain metastases: A post-hoc analysis of CodeBreaK 100
    Meeting Abstract

    Ramalingam, S.; Skoulidis, F.; Govindan, R.; Velcheti, V.; Li, B.; Besse, B.; Dy, G.; Kim, D.; Schuler, M.; Vincent, M.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Associating cardiac plaque accumulation with cardiac toxicity and overall survival in locally advanced non-small cell lung cancer
    Meeting Abstract

    Haseltine, J.; Apte, A.; Jackson, A.; Yorke, E.; Yu, A.; Wu, A.; Peleg, A.; Al-Sadawi, M.; Iocolano, M.; Gelblum, D.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Long-term outcomes and characteristics of unresectable locally advanced thymic malignancies
    Meeting Abstract

    Sideris, A.; Li, X.; Oufkir, H.; Curry, M.; Tan, K. S.; Araujo-Filho, J.; Robinson, E.; Jones, D.; Ginsberg, M.; Rimner, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • A phase 2 multicenter study of Iovance autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic NSCLC
    Meeting Abstract

    Massarelli, E.; Schoenfeld, A.; Chesney, J.; Hong, Y.; Lammers, P.; Nieva, J.; Wise-Draper, T.; Goldberg, Z.; Cacovean, A.; Yadav, B.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase 2, study of Iovance autologous tumor infiltrating lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) in patients with solid tumors
    Meeting Abstract

    Gettinger, S.; Kluger, H.; Schoenfeld, A.; Betof Warner, A.; He, K.; Sukari, A.; Thomas, S.; Doger, B.; Lee, S.; Haefliger, S.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase 3 study of first-line pembrolizumab ± vibostolimab (anti-TIGIT) in patients with PD-L1‒positive metastatic NSCLC
    Meeting Abstract

    Hellmann, M. D.; Cho, B. C.; Juergens, R.; Cheng, Y.; De Castro, G. Jr; Erman, M.; Bauman, J. R.; Takahashi, T.; Schwarzenberger, P.; Zhang, P.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • LIBRETTO-432: A placebo-controlled phase 3 study of adjuvant selpercatinib in stage IB-IIIA RET fusion-positive NSCLC
    Meeting Abstract

    Goldman, J.; Besse, B.; Wu, Y.; Yang, J. C.; Paz-Ares, L.; Drilon, A.; Johnson, M.; Xia, M.; Chao, B. H.; Tsuboi, M.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase II randomized trial to evaluate prednisone taper with or without nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z.; Lobaugh, S.; Zhang, Z.; Geyer, A.; Gelblum, D.; Abdulnour, R.; Shepherd, A.; Shaverdian, N.; McCune, M.; Li, H.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Personalized optimization of TCP using NTCP based constraints for ultracentral lung tumors
    Meeting Abstract

    Chen, I.; Iyer, A.; Thor, M.; Wu, A.; Apte, A.; Rimner, A.; Gomez, D.; Deasy, J.; Jackson, A.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • DREAM3R: Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma - a phase 3 randomised trial
    Meeting Abstract

    Forde, P.; Stockler, M.; Kok, P. S.; Brown, C.; Sun, Z.; O'Byrne, K.; Yip, S.; Anagnostou, V.; Cook, A.; Lesterhuis, W. J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save